Document:

Exhibit 10.13

 

SUBSCRIPTION AGREEMENT FOR SHARES OF
COMMON STOCK

AND COMMON STOCK PURCHASE WARRANTS

 

This
SUBSCRIPTION Agreement (this “Agreement”) is made as of September 21, 2018 by, and between MYnd
Analytics, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto
(each, an “Investor,” and collectively, the “Investors”).

 

WITNESSETH

 

In consideration for
the mutual promises and covenants herein, the parties agree as follows:

 

WHEREAS, the
Company is offering, in a private placement of investment units for $1.85, consisting of shares of its Common Stock (“Common
Stock”), par value $0.001 per share (the “Shares”) and Common Stock Purchase Warrants (“Warrants”)
to purchase shares of Common Stock in a private placement to accredited investors pursuant to a Confidential Offering Memorandum
dated September 20, 2018; and

 

WHEREAS, the
undersigned desires to subscribe for and purchase the number of Shares set forth on Schedule A hereto.

 

Section
1 – Purchase and Sale of SHARES

 

1.1          Purchase
and Sale of Shares. The Company has authorized the issuance and sale, in accordance with the terms hereof, of Shares and Warrants,
provided that one (1) Warrant shall be issued for every one (1) Share. On the terms and subject to the conditions set forth
in this Agreement, at the Closings (as defined below), the Company agrees to issue to each Investor, and each Investor agrees to
purchase from the Company, the quantity of Shares and Warrants in the amount set forth on Schedule A at a price per Share
and Warrant of $1.85 USD. The Company will sell Shares and Warrants to more than one Investor,
each of whom will enter into Subscription Agreement substantially identical to this one. 

 

1.2          Closings.

 

(a)          Initial
Closing. The initial purchase and sale of the Shares and Warrants shall take place at a closing (the “Initial
Closing”) which shall take place remotely via exchange of documents and signatures at 10:00
a.m. Eastern Time on the business day immediately following execution and delivery of this Agreement, or at such other place and
time as may be agreed to among the Company and the Investors. At the Initial Closing, the Company shall deliver to each of the
Investors purchasing Shares and Warrants for cash at such initial closing, a certification in book-entry form representing such
number of Shares and Warrants as is set forth opposite such Investor’s name on Schedule A hereto against receipt of
a check subject to collection or a wire transfer in immediately available funds of the purchase price, to an account designated
by the Company. 

 

    	 

     

    

(b)          Additional
Closings. The Company shall have the right, on one or more occasions, to hold additional closings (each, an “Additional
Closing,” and, collectively with the Initial Closing, the “Closings,”
and individually, a “Closing”), pursuant to which it shall have the right
to issue and sell additional Shares to additional Investors or existing Investors. At each Additional Closing, the Company shall
deliver to each Investor purchasing Shares and Warrants at such additional closing, a certification in book-entry form representing
such number of Shares and Warrants as is set forth opposite such Investor’s name on Schedule A hereto against receipt
of a check subject to collection or a wire transfer in immediately available funds of the purchase price, to an account designated
by the Company. By receiving Shares and Warrants at an Additional Closing, each Investor so receiving Shares and Warrants thereby
represents that its representations and warranties contained in Section 3 are true and correct as of the date of such Additional
Closing.

 

The
obligation of each Investor to purchase and pay cash for the Shares and Warrants to be delivered at a Closing is, unless waived
by such Investor, subject to the condition that the Company’s representations and warranties contained in Section 2 are true,
complete and correct on and as of such Closing date. The obligation of the Company to sell and issue Shares to be delivered at
a Closing is, unless waived by the Company, subject to the condition that the relevant Investor’s representations and warranties
contained in Section 3 are true, complete and correct on and as of the Closing Date.

 

Section
2 - Representations and Warranties

of
the Company

 

The Company represents
and warrants to each Investor as follows:

 

2.1         Existence
of Company. The Company is a duly organized Delaware corporation. The Company is validly existing in all jurisdictions where
it conducts its business.

 

2.2          Authority
to Execute. The execution, delivery and performance by the Company of this Agreement and the issuance of the Shares and Warrants
are within the Company’s corporate powers, have been duly authorized by all necessary corporate action, do not and will not
conflict with any provision of law or organizational document of the Company (including its Certificate of Incorporation or Bylaws)
or of any agreement or contractual restrictions binding upon or affecting the Company or any of its property and need no further
stockholder or creditor consent.

 

2.3          No
Stockholder Approval Required. No approval of the Company’s stockholders is required for (i) the entry by the Company
into this Agreement, or (ii) the issuance of the Shares and Warrants contemplated by this Agreement.

 

2.4          Warrants.
The form of Warrant is attached hereto as Schedule B and will conform in all respects to the terms thereof.  

 

2.5          Valid
Issuance. The Shares will be, validly issued, fully paid and nonassessable and each of the Shares and the Warrants will be
free of restrictions on transfer other than restrictions on transfer under, applicable state and federal securities laws and liens
or encumbrances created by or imposed by the Investor. Assuming the accuracy of the representations of the Investor in Section
3 of this Agreement, and the Shares and the Warrants will be issued in compliance with all applicable federal and state securities
laws.

 

    	2

     

    

 

2.6          Binding
Obligation. Each of this Agreement and the Warrants is, a valid and binding obligation of the Company enforceable against the
Company in accordance with its terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium,
reorganization and similar laws affecting creditors’ rights generally and to general equitable principles.

 

2.7          Litigation.
No litigation or governmental proceeding is pending or threatened against the Company which may have a materially adverse effect
on the financial condition, operations or prospects of the Company, and to the knowledge of the Company, no basis therefore exists.

 

2.8          Intellectual
Property. To the best of the Company’s knowledge, the Company owns or possesses sufficient legal rights to all patents,
trademarks, service marks, trade names, copyrights, trade secrets, licenses, information and other proprietary rights and processes
necessary for its business as now conducted and as presently proposed to be conducted, without any known infringement of the rights
of others. There are no outstanding options, licenses or agreements of any kind relating to the foregoing proprietary rights, nor
is the Company bound by or a party to any options, licenses or agreements of any kind with respect to the patents, trademarks,
service marks, trade names, copyrights, trade secrets, licenses, information and other proprietary rights and processes of any
other person or entity other than such licenses or agreements arising from the purchase of “off the shelf” or standard
products.

 

2.9          SEC
Reports. The Company has filed all forms, reports, schedules, proxy statements, registration statements and other documents
(including all exhibits thereto) required to be filed by it with the U.S Securities and Exchange Commission (the “SEC”)
pursuant to the federal securities laws and the SEC rules and regulations thereunder, together with all certifications required
pursuant to the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) (as they have been amended since the time
of their filing, including all exhibits thereto, the “SEC Reports”). Each of the SEC Reports complied in all
material respects with the applicable requirements of the Securities Act of 1933, as amended (the “Securities Act”)
and the Securities Exchange Act of 1934, as amended, the Sarbanes-Oxley Act and the rules and regulations of the SEC under all
of the foregoing. None of the SEC Reports contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading.

 

    	3

     

    

 

Section
3 - Representations and Warranties

of
the Investors

 

Each Investor represents
and warrants to the Company as follows:

 

3.1          Authorization;
Binding Obligations; No Violation. The Investor has full power and authority to enter into this Agreement and this Agreement
constitutes a valid and legally binding obligation of the Investor, enforceable against the Investor in accordance with its terms,
subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, moratorium, reorganization and similar laws affecting
creditors’ rights generally and to general equitable principles. The execution and delivery by the Investor of this Agreement,
the consummation of the transactions contemplated hereby and thereby, and the compliance by the Investor with the terms and provisions
hereof and thereof, will not result in a default under (or give any other party the right, with the giving of notice or the passage
of time, or both, to declare a default or accelerate any obligation under) or violate any charter or similar documents of the Investor,
if other than a natural person, or any contract to which the Subscriber is a party or by which it or any of its properties or assets
are bound, or violate any requirement of law applicable to the Investor.

 

3.2          Accredited
Investor. The Investor is an “accredited investor” within the meaning of SEC Rule 501 of Regulation D promulgated
under the Securities Act.

 

3.3          Investment
for Own Account. The Shares and the Warrants are being acquired for his, her or its own account, for investment and not with
a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act.

 

3.4          Knowledge
and Experience. The Investor has such knowledge and experience in financial and business matters that (s)he is capable of evaluating
the merits and risks of an investment in the Shares and of making an informed investment decision with respect thereto, has the
ability and capacity to protect his/her interests and can bear the economic risk of the acceptance of the Shares, including a total
loss of his/her investment.

 

3.5          Opportunity
to Ask Questions. The Investor has had the opportunity to ask questions and receive answers from the Company or any authorized
person acting on its behalf concerning the Company and its business and to obtain any additional information, to the extent possessed
by the Company (or to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to
verify the accuracy of the information received by the Investor. In connection therewith, the Investor acknowledges that (s)he
has had the opportunity to discuss the Company’s business, management and financial affairs with the Company’s management
or any authorized person acting on its behalf.

 

3.6.         Receipt
of Information. The Investor has received and reviewed all of the information concerning the Company and the Shares and the
Warrants, both written and oral, that the Investor desires. Without limiting the generality of the foregoing, the Investor has
been furnished with or has had the opportunity to acquire, and to review: all information, both written and oral, that the Investor
desires with respect to the Company’s business, management, financial affairs and prospects. In determining whether to make
this investment, the Investor has relied solely on his/her own knowledge and understanding of the Company and its business and
prospects based upon the Investor’s own due diligence investigations and the Company’s filings with the SEC.

 

3.7          Disqualification.
No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Investor or, to the Investor's knowledge, any Covered Person (as hereinafter defined), except
for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Covered Person”
means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any
individual listed in the first paragraph of Rule 506(d)(1) of the Securities Act.

 

    	4

     

    

 

Section
4 - Miscellaneous

 

4.1           No
Waiver; Cumulative Remedies. No failure or delay on the part of any party to this Agreement in exercising any right or remedy
under, or pursuant to, this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right,
remedy or power preclude other or further exercise thereof, or the exercise of any other right, remedy or power. The remedies in
this Agreement are cumulative and are not exclusive of any remedies provided by law.

 

4.2           Amendments
and Waivers. Except as otherwise expressly set forth in this Agreement, any term of this Agreement may be amended (either retroactively
or prospectively) with the written consent of the Company and Investors owning a majority of the Shares purchased in the Offering
Majority Holders. Any amendment effected in accordance with this Section 4.2 shall be binding upon each Investor, each future holder
of Shares and the Company.

 

4.3           Notices,
Etc. All notices, requests, consents and other communications hereunder to any party shall be deemed to be sufficient if contained
in a written instrument delivered in person; sent by facsimile transmission; sent by electronic mail; duly sent by first class
registered or certified mail, return receipt requested, postage prepaid; or duly sent by overnight delivery service (e.g.,
Federal Express) addressed to such party (i) if to the Company, at the address, fax number or electronic mail address, as applicable,
set forth on the signature page hereof or (ii) if to an Investor, at the address, fax number or electronic mail address, as applicable,
set forth on Schedule A hereto, or at such other address, fax number or electronic mail address as may hereafter be designated
in writing by the addressee to the sender. All such notices, advises and communications shall be deemed to have been received:
(a) in the case of personal delivery, on the date of such delivery; (b) in the case of facsimile or electronic mail transmission,
on the date of transmission; and (c) in the case of mailing or delivery by service, on the date of delivery as shown on the return
receipt or delivery service statement.

 

4.4           Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard
to the conflicts of law provisions of the State of Delaware or of any other state. The Company and each Investor consent to personal
jurisdiction in New York County, New York.

 

4.5           Severability.
If any term in this Agreement is held to be illegal or unenforceable, the remaining portions of this Agreement shall not be affected,
and this Agreement shall be construed and enforced as if this Agreement did not contain the term held to be illegal or unenforceable.

 

4.6           Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the Company and each Investor and their respective
successors and assigns.

 

    	5

     

    

 

4.7           Transfer
of Shares and Warrants. Notwithstanding the legend required to be placed on the Shares and Warrants by applicable law, no registration
statement or opinion of counsel shall be necessary: (a) for a transfer of Shares and Warrants to the respective estate of each
Investor or for a transfer of Shares and Warrants by gift, will or intestate succession of each Investor to his or her spouse or
to the siblings, lineal descendants or ancestors each Investor or his or her spouse, if the transferee agrees in writing to be
subject to the terms hereof to the same extent as if he or she were the original Investor hereunder; or (b) for a transfer of Shares
and Warrants pursuant to SEC Rule 144 or any successor rule, or for a transfer of Shares and Warrants pursuant to a registration
statement declared effective by the SEC under the Securities Act relating to the Shares and Warrants.

 

4.8           Survival
of Representations, Warranties and Covenants. The representations and warranties of the parties contained in or made pursuant
to this Agreement shall survive the execution and delivery of this Agreement indefinitely, and shall in no way be affected by any
investigation of the subject matter thereof made by or on behalf of the other parties. The covenants of the parties contained in
or made pursuant to this Agreement shall survive the execution and delivery of this Agreement until such time as the Notes have
been paid in full.

 

4.9           Entire
Agreement. This Agreement the Warrant constitute the full and entire understanding and agreement between the parties with respect
to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the
parties are expressly canceled.

 

4.10         Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an original but all of which together shall
constitute one and the same instrument.

 

4.11         California
Commissioner of Corporations. THE SALE OF THE SHARES AND WARRANTS WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED
WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SHARES AND WARRANTS OR PAYMENT OR RECEIPT
OF ANY PART OF THE CONSIDERATION FOR SUCH SHARES AND WARRANTS PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SHARES
IS EXEMPT FROM QUALIFICATIONS BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO
THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.

 

[Remainder of Page Intentionally Left
Blank]

 

    	6

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed and delivered by their proper and duly authorized officers as
of the date first written above.

 

	 	MYND
    ANALYTICS, INC.
	 	 
	 	By:	 
	 	 	Name:  Donald
    D'Ambrosio
	 	 	Title:    Chief
    Financial Officer

 

Address/Fax Number/E-mail Address for Notice:

 

26522 La Alameda

Mission Viejo, CA 92691

Fax: (866) 867 4446

ddambrosio@myndanalytics.com

 

	 	INVESTOR:
	 	 	 
	 	By:	 
	 	 	Name: 
	 	 	 
	 	 	 
	 	 	Title: 

 

[SIGNATURE PAGE
TO SUBSCRIPTION AGREEMENT]

 

    	 

     

    

 

SCHEDULE A

 

	Name, Address, Fax Number, E-Mail Address and Tax 

ID Number of Investor 	
        Aggregate Purchase Price
 

	
         

         

        Name:_________________________________

         

        Address:_______________________________

         

        ______________________________________

         

        Fax:__________________________________

         

        Email:_________________________________

         

        Tax ID:________________________________

         
	
         

        (A) Quantity of Shares and Warrants: ___,___

         

        (B) Price per Share and Warrant:

        $1.85

         

        Aggregate Purchase Price (A) x (B):

         

        $______________________

	TOTAL:Exhibit 10.14

 

THIS WARRANT AND THE SECURITIES ISSUABLE
UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933, AS AMENDED OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED.

 

	Warrant No. ___________	September 24, 2018

 

FORM OF WARRANT TO PURCHASE SHARES OF
COMMON STOCK

 

This Warrant is issued to ________________
(“Holder”) by MYnd Analytics, Inc., a Delaware corporation (the “Company”), in connection
with the issuance to the Holder of shares of Series A Preferred Stock of the Company pursuant to a Subscription Agreement of even
date herewith ("Subscription Agreement") among the Company and the signatories thereof. All capitalized terms
not defined in this Warrant shall have the meaning ascribed to them in the Subscription Agreement. This Warrant is one of a series
of Warrants issued in connection with and pursuant to the Subscription Agreement.

 

1.            Purchase
of Shares.  Subject to the terms and conditions hereinafter set forth, the holder of this Warrant is entitled, upon
surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the holder
hereof in writing), to purchase from the Company up to ______________fully paid and nonassessable Shares (as defined below)
at the Exercise Price (as defined below).

 

2.            Definitions.

 

(a)          Exercise
Price.  The exercise price for the Shares initially shall be $2.00 per share, as adjusted from time to time
(such price, as adjusted from time to time, is herein referred to as the “Exercise Price”).

 

(b)          Exercise
Period.  This Warrant shall be exercisable, in whole or in part, during the term commencing six months from the date
hereof and ending at 5:00 p.m. New York time on September 23, 2023 subject to the restrictions in Section 17 hereof.

 

(c)          The
Shares.  The term “Shares” shall mean shares of the Company’s common stock, par value $0.001
per share.

 

3.            Method
of Exercise.  While this Warrant remains outstanding and exercisable in accordance with the terms hereof, the holder
may exercise, in whole or in part, the purchase rights evidenced hereby.  Such exercise shall be effected by:

 

(i)          the
surrender of the Warrant, together with a notice of exercise in substantially the form attached hereto as Exhibit A to the
Secretary of the Company at its principal offices; and

 

(ii)         the
payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased, in cash (through
a check payable to the Company or by wire transfer to an account designated by the Company).

 

4.            Certificates
for Shares.  Upon the exercise of the purchase rights evidenced by this Warrant, one or more certificates for the
number of Shares so purchased shall be issued as soon as practicable thereafter, and in any event within thirty (30) days of the
delivery of the subscription notice.

 

5.            Issuance
of Shares.  The Company covenants that the Shares, when issued pursuant to the exercise of this Warrant, will be
duly and validly issued, fully paid and nonassessable and free from all taxes, liens, and charges with respect to the issuance
thereof. The Company shall at all times reserve and keep available solely for the issuance and delivery upon the exercise of this
Warrant, such number of Shares sufficient to permit the exercise in full of this Warrant.

 

    	1

     

    

 

6.            Adjustment
of Exercise Price and Number of Shares.  The number of and kind of securities purchasable upon exercise of this Warrant
and the Exercise Price shall be subject to adjustment from time to time as follows:

 

(a)          Subdivisions,
Combinations and Other Issuances.  If the Company shall at any time prior to the expiration of this Warrant subdivide
the Shares, by split-up or otherwise, or combine its Shares, or issue additional shares as a dividend, the number of Shares issuable
on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or
proportionately decreased in the case of a combination.  Appropriate adjustments shall also be made to the purchase price
payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted)
shall remain the same.  Any adjustment under this Section 6(a) shall become effective at the close of business on the
date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record
date is fixed, upon the making of such dividend.

 

(b)          Reclassification,
Reorganization and Consolidation.  In case of any reclassification, capital reorganization, or change in the capital
stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 6(a) above),
then the Company shall make appropriate provision so that the holder of this Warrant shall have the right at any time prior to
the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind
and amount of shares of stock and other securities and property receivable in connection with such reclassification, reorganization,
or change by a holder of the same number of Shares as were purchasable by the holder of this Warrant immediately prior to such
reclassification, reorganization, or change.  In any such case appropriate provisions shall be made with respect to the
rights and interest of the holder of this Warrant so that the provisions hereof, including Sections 6(a), shall thereafter be applicable
with respect to any shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments
shall be made to the purchase price per share payable hereunder, provided the aggregate purchase price shall remain the same.

 

(c)          Notice
of Adjustment.  When any adjustment is required to be made in the number or kind of shares purchasable upon exercise
of the Warrant, or in the Exercise Price, the Company shall promptly notify the holder of such event and of the number of Shares
or other securities or property thereafter purchasable upon exercise of this Warrant, and furnish the holder with a certificate
of its Chief Financial Officer, including computations of such adjustment in the number or kind of shares purchasable upon exercise
of the Warrant, or in the Exercise Price.

 

7.            No
Fractional Shares or Scrip.  No fractional shares or scrip representing fractional shares shall be issued upon the
exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of
the Exercise Price then in effect.

 

8.            Restrictive
Legend.

 

The Shares (unless registered under the Securities Act of 1933,
as amended (the “Act”)) shall be stamped or imprinted with a legend in substantially the following form:

 

THE SHARES REPRESENTED BY THIS
CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF,
AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED
IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.  COPIES
OF THE AGREEMENT COVERING THE PURCHASE OF THESE SHARES AND RESTRICTING THEIR TRANSFER MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST
MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY.

 

    	2

     

    

 

THE SALE OF SECURITIES WHICH ARE
THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE
OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS
THE SALE OF SECURITIES IS EXEMPT FROM THE QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE.  THE
RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED UNLESS THE SALE IS SO EXEMPT.

 

9.            Warrants
Transferable.  Subject to compliance with the terms and conditions of this Section 9, this Warrant and all rights
hereunder are transferable, in whole or in part, without charge to the holder hereof (except for transfer taxes), upon surrender
of this Warrant properly endorsed or accompanied by written instructions of transfer.  With respect to any offer, sale
or other disposition of this Warrant or any Shares acquired pursuant to the exercise of this Warrant prior to registration of such
Warrant or Shares, the holder hereof agrees to give written notice to the Company prior thereto, describing briefly the manner
thereof, together with a written opinion of such holder’s counsel, or other evidence, if requested by the Company, to the
effect that such offer, sale or other disposition may be effected without registration or qualification (under the Act as then
in effect or any federal or state securities law then in effect) of this Warrant or the Shares and indicating whether or not under
the Act certificates for this Warrant or the Shares to be sold or otherwise disposed of require any restrictive legend as to applicable
restrictions on transferability in order to ensure compliance with such law; provided, however, the Company shall not require an
opinion of counsel in any transaction in compliance with Rule 144 promulgated by the SEC under the Act.  Upon receiving
such written notice and reasonably satisfactory opinion or other evidence, if so requested, the Company, as promptly as practicable,
shall notify such holder that such holder may sell or otherwise dispose of this Warrant or such Shares, all in accordance with
the terms of the notice delivered to the Company.  If a determination has been made pursuant to this Section 9 that the
opinion of counsel for the holder or other evidence is not reasonably satisfactory to the Company, the Company shall so notify
the holder promptly with details thereof after such determination has been made.  Each certificate representing this
Warrant or the Shares transferred in accordance with this Section 9 shall bear a legend as to the applicable restrictions on transferability
in order to ensure compliance with such laws, unless in the aforesaid opinion of counsel for the holder, such legend is not required
in order to ensure compliance with such laws.  The Company may issue stop transfer instructions to its transfer agent
in connection with such restrictions.   Notwithstanding the foregoing, Holder may assign this Warrant or the Shares
into which such Warrant may be converted to an affiliated entity without the prior written consent of the Company so long as such
assignment complies with applicable law.

 

10.          Rights
of Stockholders.  No holder of this Warrant shall be entitled, as a Warrant holder, to vote or receive dividends
or be deemed the holder of the Shares or any other securities of the Company which may at any time be issuable on the exercise
hereof for any purpose, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any
of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to
stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization,
issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive
notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant shall have been exercised and
the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein.

 

    	3

     

    

 

11.          Amendments
and Waivers.  Any provision of this Warrant may be amended, waived or modified upon the written consent of the Company
and the Majority Holders.  Any such amendment, waiver or modification effected in accordance with this paragraph
shall be binding upon the Company and Holder, it being understood and agreed that such written consent will affect all Warrants
and be binding on all holders thereof regardless of whether any particular holder executed such consent. Notwithstanding the above,
neither the exercise price nor the number of shares issuable upon exercise hereof may be amended or modified, other than as expressly
provided for herein. Any change to this Warrant shall be made to all Warrants of this series issued pursuant to the Subscription
Agreements with the holders thereof.

 

12.          Notices
of Certain Transactions.  In case (a) the Company shall take a record of the holders of its outstanding stock of
the same class as the Shares purchasable under this Warrant (or other stock or securities at the time deliverable upon the exercise
of this Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any
right to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right, to
subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right, (b) of any capital
reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company
with or into another corporation (other than a consolidation or merger in which the shares of capital stock of the Company outstanding
immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital
stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital
stock of the surviving corporation), or any transfer of all or substantially all of the assets of the Company, or (c) of the voluntary
or involuntary dissolution, liquidation or winding-up of the Company, then, and in each such case, the Company will mail or cause
to be mailed to the holder of this Warrant a notice specifying, as the case may be, (i) the date on which a record is to be taken
for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution or
right, or (ii) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution,
liquidation, redemption or conversion is to take place, and the time, if any is to be fixed, as of which the holders of record
of the Company’s outstanding stock of the same class as the Shares purchasable under this Warrant (or such other stock or
securities at the time deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation,
redemption or conversion) are to be determined. Such notice shall be mailed at least ten (10) days prior to the record date or
effective date for the event specified in such notice.

 

13.          Notices.  All
notices and other communications given or made hereunder shall be in writing and shall be deemed effectively given: (a) upon personal
delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours
of the recipient, and if not so confirmed, then on the next business day, with a copy to be sent by United States first class mail,
postage prepaid, (c) five (5) days after being sent by registered or certified mail, return receipt required, postage prepaid,
or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification
of receipt.  All communications shall be sent to the respective parties at their address or fax number as set forth on
the signature page to the Subscription Agreement or to such electronic mail address, facsimile number or address as subsequently
modified by written notice given in according with this Section 13.

 

14.          No
Impairment.  The Company shall not, by amendment of its certificate of incorporation or through reorganization, consolidation,
merger, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any
of the terms of this Warrant, but shall at all times in good faith assist in the carrying out of all such terms and in the taking
of all such action as may be necessary or appropriate in order to protect the rights of the holder of this Warrant against impairment.

 

15.          Governing
Law.  This Warrant and all actions arising out of or in connection with this Warrant shall be governed by and construed
in accordance with the laws of the State of Delaware, without regard to the conflicts of law provisions of the State of Delaware
or of any other state.

 

16.          Rights
and Obligations Survive Exercise of Warrant.  Unless otherwise provided herein, the rights and obligations of the
Company, of the holder of this Warrant and of the holder of the Shares issued upon exercise of this Warrant, shall survive the
exercise of this Warrant.

 

    	4

     

    

 

17.          Beneficial
Ownership Limitation. Notwithstanding anything herein to the contrary, the Company shall not effect any exercise of this Warrant,
and a holder shall not have the right to exercise any portion of this Warrant, to the extent that, after giving effect to an attempted
exercise set forth on an applicable Notice of Exercise and any transactions relating thereto, such holder (together with and any
other person whose beneficial ownership of Common Stock would be aggregated with the holder's for purposes of Section 13(d) of
the Securities Exchange Act of 1934, as Amended (the "Exchange Act") would beneficially own a number of shares of Common
Stock in excess of the Beneficial Ownership Limitation (as defined below). The "Beneficial Ownership Limitation" shall
be 19.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock pursuant to such Notice of Exercise (to the extent permitted pursuant to this Section 17); provided, however, that
by written notice to the Company, which will not be effective until the 61st day after such notice is delivered to the Company,
the holder may waive or amend the provisions of this Section 17 to change the Beneficial Ownership Limitation to any other number
less than or equal to 19.99%, and the provisions of this Section 17 shall continue to apply. The Company be entitled to rely on
representations made to it by the Holder in any Notice of Conversion regarding its Beneficial Ownership Limitation.

 

[Signature Page Follows]

 

    	5

     

    

 

Issued this ___ day of ________, 2018.

 

	 	MYND ANALYTICS, INC.
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	Address:	26522 La Alameda
	 	 	Mission Viejo, CA  92691

 

	Accepted and agreed:	 
	 	 
	 	 
	 	 
	 	 
	Name and Position	 
	 	 
	Address:	 

 

[Signature Page to Form of Warrant]

 

    	 

     

    

 

EXHIBIT A

 

NOTICE OF EXERCISE

 

	TO:	MYnd Analytics, Inc.	 
	 	 	 
	 	 	 

 

Attention: Chief Executive Officer

 

1.           The
undersigned hereby elects to purchase __________ Shares of _____________ pursuant to the terms of the attached Warrant.

 

2.           Please
issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified
below:

 

	 
	(Name)
	 
	 
	(Address)

 

3.           The
undersigned hereby represents and warrants that the aforesaid Shares are being acquired for the account of the undersigned for
investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no
present intention of distributing or reselling such shares and all representations and warranties of the undersigned set forth
in the attached Warrant are true and correct as of the date hereof.

 

	 	 	 
	 	 	(Signature)
	 	 	 
	 	 	 
	 	 	(Name)
	 	 	 
	 	 	 
	(Date)	 	(Title)

 

    	 

     

    

 

FORM OF TRANSFER

(To be signed only upon transfer of Warrant)

 

FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto _______________________________________________ the right represented by the attached Warrant
to purchase ____________ shares of  ________________________ of MYnd Analytics, Inc. to which the attached Warrant relates,
and appoints ______________ Attorney to transfer such right on the books of __________, with full power of substitution in the
premises.

 

	Dated: ____________________

 

	 	 	 
	 	 	(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)
	 	 	Address:	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	Signed in the presence of:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]